LRRK2 and Parkinson disease: A recent study found a statistically significant decrease in Serine 935 phosphorylation of LRRK2 in human peripheral blood mononuclear cells (PBMCs) derived from LRRK2 G2019S mutation carriers with PD but not G2019S non-manifesting mutation carriers when compared to iPD [35].